View Cart
My AccountInfectious Disease Diagnostic Solutions
Microbix Phone+1803294983432Microbix Emailcustomer.service@microbix.com
Microbix Logo
Request Catalogue Contact Us
  • Services
    • Assay Development Solutions
    • Custom Vial Filling Services
  • Products
    • Reference Materials (QUANTDx™)
    • Antigens
      • All Antigens
      • Childhood Disease Antigens
      • Dengue Antigens
      • STI Antigens
      • ToRCH Antigens
      • Respiratory Antigens
      • Other Antigens
    • External Quality Controls (QAPs™)
      • All External QC Products
      • Respiratory Viral Panel
      • STI Panel
      • HPV Panel
      • Gastrointestinal Panel
      • Genital Ulcer Panel
      • Vaginal Infections Panel
      • ONBOARDx Kits
      • Proficiency Testing Panel
      • Technical Resources
    • DxTM™ Viral Transport Medium
    • Control Elution Buffer
    • Kinlytic (Urokinase)
  • About
    • Who We Are
    • Who We Work With
    • Quality
    • Board of Directors
    • Our Senior Team
    • Careers
  • Resources
    • Catalogues & Brochures
    • White Papers
    • Poster Publication
    • Podcasts
  • Investors
    • News Releases
    • Financial Reports
    • Corporate Presentations
    • Analyst Coverage
    • Corporate Governance
    • Stock Information
Contact Us
Microbix Presenting at Muskoka Capital Event

Microbix Presenting at Muskoka Capital Event

by Aayat Punjabi | Sep 25, 2025 | Blog, Media Features News Releases, News Releases

Meetings with Growth-Oriented Investors, September 26 to 28, 2025   MISSISSAUGA, CANADA, September 25, 2025 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it will be...
Microbix Assisting EMQN with Second Genetic-Test EQA Program

Microbix Assisting EMQN with Second Genetic-Test EQA Program

by Aayat Punjabi | Sep 23, 2025 | Blog, Media Features News Releases, News Releases

Helping Ensure Appropriate Dosing of Widely-Used Anti-Clotting Drugs   MISSISSAUGA, CANADA & MANCHESTER, UK – September 23, 2025 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, and EMQN...
Microbix Hosts Ontario Minister Stephen Crawford

Microbix Hosts Ontario Minister Stephen Crawford

by Aayat Punjabi | Sep 3, 2025 | Blog, Media Features News Releases, News Releases

Site Visit & Discussions at Biotech Manufacturing Facilities in Mississauga   MISSISSAUGA, CANADA, September 3, 2025 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces its...
Microbix Reports Results for Q3 Fiscal 2025

Microbix Reports Results for Q3 Fiscal 2025

by Aayat Punjabi | Aug 14, 2025 | Blog, Media Features News Releases, News Releases

Revenues of $3.5 million, Weaker Gross Margin, and Net Loss   MISSISSAUGA, CANADA, August 14, 2025 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its third quarter...
Microbix Schedules Release of Results for Q3 Fiscal 2025

Microbix Schedules Release of Results for Q3 Fiscal 2025

by Aayat Punjabi | Aug 7, 2025 | Blog, Media Features News Releases, News Releases

Results Release and Webinar Discussion on Morning of August 14, 2025   MISSISSAUGA, CANADA, August 7, 2025 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it expects to...
« Older Entries
  • Investors
  • Legal
  • Contact
  • News Releases
  • Accessibility
  • Careers
Microbix Funded By